Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cytotherapy|April 21, 2018
Scanning the horizon for high value-add manufacturing science: Accelerating manufacturing readiness for the next generation of disruptive, high-value curative cell therapeuticsPaul Hourd, David J Williams
Regenerative Medicine|November 14, 2015
A 3D bioprinting exemplar of the consequences of the regulatory requirements on customized processesPaul Hourd, Nicholas Medcalf, Joel Segal, et al.
Journal of Tissue Engineering and Regenerative Medicine|October 21, 2009
Human cell culture process capability: a comparison of manual and automated productionYang Liu, Paul Hourd, Amit Chandra, et al.
Cytotherapy|May 27, 2014
Manufacturing models permitting roll out/scale out of clinically led autologous cell therapies: regulatory and scientific challenges for comparabilityPaul Hourd, Patrick Ginty, Amit Chandra, et al.
Biopreservation and Biobanking|May 20, 2014
Mesenchymal stem cell isolation from human umbilical cord tissue: understanding and minimizing variability in cell yield for process optimizationAndreea Iftimia-Mander, Paul Hourd, Roger Dainty, et al.
Regenerative Medicine|March 12, 2011
Regenerative medicine, resource and regulation: lessons learned from the remedi projectPatrick J Ginty, Erin A Rayment, Paul Hourd, et al.
Regenerative Medicine|June 19, 2019
The management of risk and investment in cell therapy process development: a case study for neurodegenerative diseaseSujith Sebastian, Paul Hourd, Amit Chandra, et al.
Tissue Engineering. Part C, Methods|May 8, 2014
A quality-by-design approach to risk reduction and optimization for human embryonic stem cell cryopreservation processesPeter D Mitchell, Elizabeth Ratcliffe, Paul Hourd, et al.
Regenerative Medicine|December 25, 2012
Application of response surface methodology to maximize the productivity of scalable automated human embryonic stem cell manufactureElizabeth Ratcliffe, Paul Hourd, Juan Guijarro-Leach, et al.
Regenerative Medicine|November 29, 2014
Qualification of academic facilities for small-scale automated manufacture of autologous cell-based productsPaul Hourd, Amit Chandra, David Alvey, et al.
Pageof 2